Scholarlink

Group B Streptococcus (GBS) is a human pathogen and a leading cause of neonatal meningitis, pneumonia, and sepsis in newborns and adults. Group B Streptococcal meningitis is caused when blood-borne GBS interacts with and disrupts the blood-brain barrier, causing inflammation. The blood-brain barrier (BBB) is comprised of highly specialized brain endothelial cells (BECs) that serve as the interface between the circulation and the central nervous system (CNS), creating a tight endothelial cell barrier. Modeling the BBB using an induced pluripotent stem-cell (iPSC)-derived brain-like endothelial cell model (iBEC) allows for robust expression and retention of BBB phenotypes when compared to other in vitro models. This chapter describes the derivation of iBECs, the culture of GBS, and the use of various molecular biology techniques to closely investigate the host–pathogen interactions between the blood-brain barrier and Group B Streptococcus.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Studying Group B Streptococcus–Blood-Brain Barrier Interaction In Vitro Using an Induced Pluripotent Stem-Cell-Derived Brain-Like Endothelial Cell Model

  • 实验方案

  • 发表日期：

    2025年

查看全文
  • Natalie G. Alexander,
  • Sarah F. Hathcock,
  • Brandon J. Kim

摘要

Group B Streptococcus (GBS) is a human pathogen and a leading cause of neonatal meningitis, pneumonia, and sepsis in newborns and adults. Group B Streptococcal meningitis is caused when blood-borne GBS interacts with and disrupts the blood-brain barrier, causing inflammation. The blood-brain barrier (BBB) is comprised of highly specialized brain endothelial cells (BECs) that serve as the interface between the circulation and the central nervous system (CNS), creating a tight endothelial cell barrier. Modeling the BBB using an induced pluripotent stem-cell (iPSC)-derived brain-like endothelial cell model (iBEC) allows for robust expression and retention of BBB phenotypes when compared to other in vitro models. This chapter describes the derivation of iBECs, the culture of GBS, and the use of various molecular biology techniques to closely investigate the host–pathogen interactions between the blood-brain barrier and Group B Streptococcus.